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OBJECTIVE — To report the prevalence and incidence of type 1 and type 2 diabetes among
African American youth and to describe demographic, clinical, and behavioral characteristics.
RESEARCH DESIGN AND METHODS — Data from the SEARCH for Diabetes in
Youth Study, a population-based, multicenter observational study of youth with clinically diag-
nosed diabetes aged 0–19 years, were used to estimate the prevalence for calendar year 2001
(692 cases) and incidence based on 748 African American case subjects diagnosed in 2002–
2005. Characteristics of these youth were obtained during a research visit for 436 African
American youth with type 1 diabetes and 212 African American youth with type 2 diabetes.
RESULTS — Among African American youth aged 0–9 years, prevalence (per 1,000) of type
1 diabetes was 0.57 (95% CI 0.47–0.69) and for those aged 10–19 years 2.04 (1.85–2.26).
Among African American youth aged 0–9 years, annual type 1 diabetes incidence (per 100,000)
was 15.7 (13.7–17.9) and for those aged 10–19 years 15.7 (13.8–17.8). A1C was 9.5% among
50% of youth with type 1 diabetes aged 15 years. Across age-groups and sex, 44.7% of African
American youth with type 1 diabetes were overweight or obese. Among African American youth
aged 10–19 years, prevalence (per 1,000) of type 2 diabetes was 1.06 (0.93–1.22) and annual
incidence (per 100,000) was 19.0 (16.9–21.3). About 60% of African American youth with type
2 diabetes had an annual household income of $25,000. Among those aged 15 years, 27.5%
had an A1C 9.5%, 22.5% had high blood pressure, and, across subgroups of age and sex,
90% were overweight or obese.
CONCLUSIONS — Type 1 diabetes presents a serious burden among African American
youth aged 10 years, and African American adolescents are impacted substantially by both type
1 and type 2 diabetes.
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Consistent with pattern of disease oc-currence in adults, type 2 diabetesin youth is more common among
nonwhite populations, including African
Americans, than among non-Hispanic
white (NHW) populations (1). The bur-
den of type 1 diabetes in African Ameri-
can youth has been less emphasized in the
literature than that of type 2 diabetes. The
SEARCH for Diabetes in Youth Study
(SEARCH study) (2) reported that among
youth aged 10–19 years, the estimated
prevalence of type 1 diabetes in 2001
among African American youth was 2.07
per 1,000 compared with 1.05 per 1,000
for type 2 diabetes, thus demonstrating
that type 1 diabetes is an important con-
tributor to the overall health status of the
population of African American youth.
African American individuals with di-
abetes have a higher risk for the chronic
complications of diabetes than NHW
Americans (3), particularly for diabetic
nephropathy (4). In 1998, Harris et al. (5)
reported an increased prevalence of dia-
betic retinopathy among African Ameri-
can compared with NHW subjects that
was explained in part by higher A1C in
African American participants. A recent
meta-analysis confirmed systematically
higher A1C among African American in-
dividuals with diabetes compared with
white counterparts (6), which may con-
tribute to ongoing racial disparities in the
occurrence of diabetes complications.
The SEARCH study provides the oppor-
tunity to estimate the prevalence and in-
cidence of type 1 and type 2 diabetes in
African American youth and to describe,
in detail, important clinical and behav-
ioral characteristics that will accrue over
their lifetime and that may contribute to
risk for the many complications of diabetes.
RESEARCH DESIGN AND
METHODS — Data for these analyses
derive from the SEARCH study. A de-
tailed description of SEARCH study
methods has been published elsewhere
(7). The SEARCH study is a multicenter
observational study that began conduct-
ing population-based ascertainment of
cases of nongestational diabetes in youth
aged 20 years beginning in 2001 and
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continuing through the present. The
SEARCH study has six clinical centers lo-
cated in Ohio, Colorado, Washington,
South Carolina, Hawaii, and California.
Youth with diabetes were identified in
geographically defined populations in
Ohio (eight urban and suburban counties
encompassing and surrounding Cincin-
nati), Washington (five urban counties
encompassing and surrounding Seattle),
South Carolina, and Colorado (selected
counties in 2001, all counties in subse-
quent years); among managed health care
plan enrollees in Hawaii and southern
California; and among Indian Health Ser-
vice beneficiaries in four American Indian
populations.
The SEARCH study sought to identify
all existing (prevalent) cases of diabetes in
2001 and all newly diagnosed (incident)
cases in subsequent years. Diabetes cases
were considered valid if diagnosed by a
health care provider. Analyses herein in-
clude prevalent (2001) and incident cases
(2002–2005). Before implementation of
the protocol, the study was reviewed and
approved by the local institutional review
board(s) that had jurisdiction over the lo-
cal study population, and compliance
with the Health Insurance Portability and
Accountability regulations was ensured.
All study personnel were trained in study
procedures before initiation of data col-
lection and then recertified annually.
Data collection
Youth with diabetes or their parent/
guardian were asked to complete a short
initial survey that collected information
on race and ethnicity and diabetes-related
factors. Self-reported race and ethnicity
were collected using the 2000 U.S. Cen-
sus questions (8). All youth who replied
to the initial survey, excluding those
whose diabetes was secondary to other
conditions, were invited to a study visit.
Written informed consent and assent
was obtained according to the guidelines
established by the local institutional re-
view board at the beginning of the study
visit. During this visit, additional survey
information was collected, including
symptoms at presentation, medications,
medical care utilization, perceptions of
care, and family history. Information
about dietary intake, physical activity and
other health behaviors, and depressive
symptoms was collected from partici-
pants aged 10 years. This information
was not shared with the parent/legal
guardian in accordance with written con-
sent by the parent/legal guardian. Dietary
intake was assessed by a food frequency
instrument modified for administration
in youth and designed to capture region-
ally and culturally specific foods in the
SEARCH study population, as previously
described (9). Physical activity questions
were derived from the Youth Risk Behav-
ioral Surveillance System questionnaire
(10). Depressive symptoms were assessed
using the Center for Epidemiologic Stud-
ies Depression Scale (CES-D) score, as
previously reported (11,12).
For all participants, blood was drawn
for measurement of diabetes autoantibod-
ies, A1C, fasting glucose, C-peptide, and
lipids. Specific laboratory methods for
these tests have been previously de-
scribed (7,13). For youth aged 3 years,
a brief physical examination included
height, weight, and waist circumference;
evaluation for acanthosis nigricans; and
measurement of systolic and diastolic
blood pressure.
Categorization of key variables
Diabetes type was reported by the health
care professional or abstracted from the
medical records as type 1, type 1a, type
1b, type 2, maturity-onset diabetes of the
young, hybrid, or other type. For this re-
port, we have restricted our analyses to
youth with type 1 (including type 1a and
type 1b) or type 2 diabetes. Cases with
maturity-onset diabetes of the young, hy-
brid, other types, or missing type were
excluded from the present analyses (2.8%
of registered African American case
subjects).
Race/ethnicity was categorized some-
what differently for the prevalence and in-
cidence estimates using all registered
youth than it was in the analysis of re-
spondent characteristics based only on
those who had a study visit. For both
analyses, all participants who reported
“Hispanic” ethnicity were categorized as
“Hispanic,” regardless of race. For the
prevalence and incidence estimates, par-
ticipants who reported multiple race cat-
egories were race bridged using methods
developed by the National Center for
Health Statistics (8). Participants with
missing race and ethnicity data or those
classified as “other race” were race
bridged or geocoded (7.6% of registered
case subjects were race bridged or geo-
coded). For analyses of characteristics of
youth with diabetes, among non-
Hispanics, those who reported more than
one race were placed into a single race
category using the National Center for
Health Statistics plurality approach (8).
Subjects who could not be classified to
one race group using the plurality ap-
proach (0.5% of case subjects with a study
visit) and those with missing data (0.02%
of those with a study visit) were excluded.
A1C was categorized using the Amer-
ican Diabetes Association guidelines as
good (8.0%), marginal (8.0–9.4%), or
poor (9.5%) (14). Values to define high
triglycerides and low HDL cholesterol
were based on age-appropriate defini-
tions of components of the metabolic syn-
drome (15) used previously by the
SEARCH study (16). High LDL choles-
terol, high apolipoprotein B, and high
albumin-to-creatinine ratio were based
on published clinical practice guidelines
(17,18). High blood pressure was defined
based on either systolic or diastolic blood
pressure and age-, height-, and sex-
specific 95th percentile (19). Other sur-
vey-based information related to blood
pressure was also considered, including
self-report of having been told by a health
care provider of a diagnosis of high blood
pressure and, based on a medication in-
ventory, self-report of taking medicine
known to lower blood pressure. Diabetic
ketoacidosis (DKA) at diagnosis was re-
ported for incident cases only and is based
on having at least one of the following
criteria noted in the medical record: 1)
blood bicarbonate 15 mmol/l or pH
7.25 (venous) or 7.30 (arterial or cap-
illary), 2) ICD-9 code 250.1 at discharge,
or 3) diagnosis of DKA mentioned in the
medical records (20). Depressive symp-
toms were categorized based on an ap-
proach developed by Rushton et al. (21)
for use with children and adolescents as
minimally (0–15), mildly (16–23), and
moderately/severely (24–60) depressed
mood.
Estimation of prevalence
Methods for estimating diabetes preva-
lence in 2001 have been previously re-
ported (2). The numerator for this
analysis included all case subjects with
nongestational diabetes prevalent in 2001
that were aged 20 years on 31 Decem-
ber 2001 and a resident of the defined
population in 2001 (geographically based
centers) or a member of the participating
health plan in 2001 (membership-based
centers). Age was based on the subject’s
age on 31 December 2001. The denomi-
nators included youth aged 20 years
who were civilian residents of the study
areas covered by the geographic centers
or were members of the specific health
plans in 2001. The prevalence of diabetes
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was expressed as cases per 1,000 youth
using data pooled across all SEARCH
study centers, with the 95% CIs calcu-
lated by using an inverted-score test from
the binomial distribution (22). While
prevalence has been previously reported
in 10-year age categories (2), we present
data in four age categories (0–4, 5–9, 10–
14, and 15–19 years) for youth with type
1 diabetes and in two age categories
(10–14 and 15–19 years) for youth with
type 2 diabetes.
Estimation of incidence rates
Annual incidence rates for 2002 and 2003
were published previously (23). Here, we
present more detailed, race/ethnic-
specific incidence rates using diabetic
case subjects ascertained with newly diag-
nosed diabetes over a 4-year period
(2002–2005). Because the 2000 U.S.
Census projections for youth residing in
the participating areas were similar in
2002 and 2003 (0.2% change overall),
for simplicity, the 2002 denominator was
multiplied by four and used as the total
denominator for case subjects ascertained
over the 4-year period of 2002–2005. The
larger numbers made available for numera-
tors and denominators by this approach al-
lowed greater stability of the rate estimation
within subgroups of race/ethnicity, age, sex,
and clinically diagnosed diabetes type. Sen-
sitivity analyses were conducted that dem-
onstrated that this approach was unlikely to
result in any quantitatively meaningful bias,
even if the true denominator increased by as
much as 5% per year, representing a cumu-
lative change up to 16% over 4 years. Cur-
rent census reports provide very little
evidence that any race/ethnic or other sub-
group studied in the SEARCH study would
have shown such a large change. If such a
dramatic change did occur, the impact on
the estimation of annual incidence rates
(per 100,000) would be 2.1 per 100,000
for high incidence rates (30/100,000) to
0.3 per 100,000 for low incidence rates
(5/100,000). The study covered
20,063,776 person-years at risk.
We assumed that with only 4 calen-
dar years of data, we would not be able to
reliably detect change over time in diabe-
tes incidence, and we therefore did not
evaluate the data for trends. Annual inci-
dence rates were estimated per 100,000
youth, and 95% CIs were calculated by
using an inverted score test from the bi-
nomial distribution (22).
Statistical testing was conducted
across subgroups of interest using 2 tests
for categorical variables, t tests for two-
group comparisons, or ANOVA models,
as appropriate. Linear or logistic regres-
sion was used to adjust for differences in
diabetes duration between age categories
for continuous and dichotomous out-
comes, respectively. Variables that were
adjusted for diabetes duration were ad-
justed using the overall SEARCH study
population. Despite the number of com-
parisons made, given the descriptive and
hypothesis-generating nature of these
analyses, we retained use of the tradi-
tional  of 0.05 to declare statistical sig-
nificance. For efficiency, data tables and
figures show results for both type 1 and
type 2 diabetes; however, results are de-
scribed first for type 1 diabetes, including
prevalence, incidence, and characteris-
tics, and then for type 2 diabetes.
RESULTS
Type 1 diabetes
Estimates of prevalence and incidence of
type 1 diabetes among African American
boys and girls are given in Fig. 1A and C.
An online table (available at http://
dx.doi.org/10.2337/dc09-s203) shows
details of numerators, denominators, and
prevalence and incidence rates with 95%
CIs. For African American girls aged
10–14 years, prevalence and incidence of
type 1 diabetes exceeded that of boys the
same age.
Socioeconomic and family character-
istics are shown in Fig. 2. More than one-
third of African American youth with type
1 diabetes had a household annual in-
come of $25,000, and 50% lived in
one-parent households.
Figure 3 displays the prevalence of
overweight and obesity. There was a sig-
nificant association between the age-
groups and BMI categories, where girls
with type 1 diabetes had higher percent-
ages of overweight and obese than boys.
Among those aged 15 years, 24% of
girls and 18.9% of boys were classified as
obese.
Clinical characteristics are presented
in Table 1. A substantial proportion of
incident case subjects aged 14 years at
the study visit presented with DKA at di-
agnosis (30.8% of youth aged 0–9 years
and 25.9% of youth aged 10–14 years).
Glycemic control was significantly associ-
ated with age, with 20.6% of youth with
type 1 diabetes aged 0–9 years having
A1C 9.5 compared with 50% of
youth aged 15 years. Results were sim-
ilar after adjustment for duration of dia-
betes. About 25% of African American
youth aged 15 years had acanthosis
nigricans.
After adjustment for diabetes dura-
tion, both systolic and diastolic blood
pressure were higher among older com-
pared with younger youth with type 1 di-
abetes (Table 1). However, the prevalence
of high blood pressure (based on mea-
surement of blood pressure) did not differ
significantly by age category and was
10%. Similarly, 10% of all youth had
been told by a health care provider they
had high blood pressure; however, this
proportion increased significantly with
age and was 12% among those aged 15
years.
The prevalence of having high LDL
cholesterol (defined as LDL cholesterol
100 mg/dl) was high in all age-groups
(57, 39.2, 65.5 for ages 0–9, 10–14, and
15 years, respectively), and 85% of all
age-groups exceeded the recent diabetes-
specific guidelines for adults of LDL cho-
lesterol 70 mg/dl (17). These guidelines
also suggest apolipoprotein B of 80
mg/dl for adults with diabetes; the preva-
lence of high apolipoprotein B was signif-
icantly higher among older compared
with younger age-groups and was 48.6%
for the age-group 15 years. The preva-
lence of having either high triglyceride or
low HDL cholesterol concentrations was
lower (25% for either lipid abnormality
across all age-groups). Less than 1% of
participants with type 1 diabetes were
taking lipid-lowering medication.
Table 2 presents behavioral and psy-
chosocial characteristics for youth with
type 1 diabetes aged 10 years. Slightly
10% had high CES-D scores suggestive
of a high degree of depression-related
symptoms. Of the dietary variables, the
recommendation most commonly met
was for consumption of dairy products;
however, nearly 70% of youth aged
10–14 years and 80% of those aged 15
years consumed less than the recom-
mended two servings per day. A majority
of youth reported participation in moder-
ate or vigorous physical activity; however,
physical inactivity was also common
(84% of youth aged 15 years reported
watching television 2 h/day).
Type 2 diabetes
Figure 1 shows prevalence and incidence
of type 2 diabetes among African Ameri-
can boys and girls, with numeric details
provided in the online appendix. Type 2
diabetes was exceedingly rare among
youth aged 10 years. During the 4 inci-
dent years, only 16 individuals were 10
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years old at diagnosis (15 girls, 1 boy) out
of a total of 298 case subjects (5%).
Girls had substantially greater prevalence
and incidence of type 2 diabetes than
boys; for example, annual incidence
among youth aged 10–14 years was 29.8/
100,000 (95% CI 24.8–35.8) among girls
compared with 12.2/100,000 (9.2–16.1)
among boys.
Nearly 60% of youth with type 2 dia-
betes lived in households with an annual
income $25,000, and 62.6% lived in
single-parent households (Fig. 2). Dis-
played in Fig. 3, the vast majority of both
boys and girls with type 2 diabetes were
obese; 10% of boys and girls were nor-
mal or underweight.
Clinical characteristics are presented
in Table 1. Type 2 diabetes was diagnosed
during a routine check-up in 41.3% of
youth aged 10 –14 years and among
34.4% of those aged 15 years, and
slightly 70% reported at least one
symptom of diabetes. Over 90% of youth
with type 2 diabetes reported a family his-
tory of diabetes. Insulin, either alone or in
combination with metformin, was used
by 43.6% of youth aged 10–14 years and
by 50% of older youth. A majority of
youth with type 2 diabetes had A1C
Figure 1—Prevalence (2001) and incidence (2002–2005) of type 1 and type 2 diabetes among African American youth according to age and sex:
the SEARCH study. , male subjects; , female subjects.
Figure 2—Markers of socioeconomic status among African American youth with type 1 and type
2 diabetes: the SEARCH study. Less income is $25,000 annual household income. Low education
is less than high school diploma. Medicare/Medicade is insurance reported by participants from
the four geographic-based sites only (health plan sites excluded).
Mayer-Davis and Associates
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8.0%, although 13.6% of those aged
10–14 years and 27.5% of older youth
had A1C 9.5%. A majority of partici-
pants with type 2 diabetes had acanthosis
nigricans.
About one-quarter of youth had high
blood pressure, and about the same pro-
portion had been told by a health care
provider that they had high blood pres-
sure. High albumin-to-creatinine ratio
was found among 15.2% of youth with
type 2 diabetes aged 10–14 years and
among 13.4% of older youth.
A majority of youth with type 2 dia-
betes exceeded consensus guidelines for
LDL cholesterol, including 95.1% of
older youth who had LDL cholesterol
70 mg/dl. After adjustment for duration
of diabetes, the prevalence of high triglyc-
erides was higher among older compared
with younger youth with type 2 diabetes
(41.6 vs. 22.1%, respectively; P  0.05).
About one-third of youth with type 2 di-
abetes had low HDL cholesterol with no
difference between age-groups.
High CES-D score was found among
9.9% of younger and among 17.4% of
older youth with type 2 diabetes (Table
2). Thirteen percent of youth aged 15
years smoked. Over 80% of youth re-
ported high intake of saturated fat and
low intake of fruits and vegetables and
dairy products. Participation in moderate
or vigorous physical activity three or more
times per week was lower in older youth
with type 2 diabetes (43.5%) compared
with younger youth (62%) (P  0.05).
Physical inactivity was observed among
75% of youth with type 2 diabetes.
CONCLUSIONS — African Ameri-
can youth aged 10 years have a rela-
tively low prevalence of type 1 diabetes,
but by the age of 10–19 years, an esti-
mated 2.17/1,000 African American girls
have type 1 diabetes, as do 1.91/1,000
African American boys (Fig. 1). The bur-
den of type 2 diabetes in African Ameri-
can youth aged 10 years is more than
twice as high among African American
girls (prevalence of 1.47/1,000 [95% CI
1.24–1.73]) than among African Ameri-
can boys (0.67/1,000 [0.53–0.86]). Afri-
can American youth with type 2 diabetes
commonly live in low socioeconomic
conditions. In adults, low socioeco-
nomic status has been associated with
increased prevalence of type 2 diabetes
(24,25). Consistent with this observa-
tion, nearly 60% of African American
youth with type 2 diabetes who partic-
ipated in the SEARCH study visit were
from households with low income. Met-
abolic control was generally poor in
youth with either type 1 or type 2 dia-
betes. Particularly across the full age
range for type 1 diabetes (0 –9 to 15
years), several metabolic parameters
were worse among older compared with
younger youth even after adjustment for
duration of diabetes.
From the worldwide DIAMOND
Study Group (26), incidence rates of type
1 diabetes ranged from 0.1 to 40.9/
100,000 per year. Incidence rates from
countries in Africa were much lower (0.8
to 1.3/100,000 per year) than those re-
ported for African Americans in the
SEARCH study or other U.S. studies (27).
Registries of childhood diabetes in the
1980s consistently reported lower inci-
dence rates for African American youth
compared with white youth. For 1990–
1994 in Allegheny County, Pennsylvania,
Lipman et al. (28) reported lower inci-
dence of insulin-treated diabetes among
nonwhite (primarily African American)
youth compared with white youth aged
10 years, nearly identical rates for non-
white and white youth aged 10–14 years,
and for youth age 15–19 years, incidence
rates were higher among nonwhite youth
(30.4/100,000 per year [95% CI 18.3–
47.4]) than among white youth (11.2/
100,000 per year [7.6–15.9]). A similar
pattern was reported from Philadelphia,
Figure 3—Overweight and obesity among African American youth with type 1 and type 2 diabetes according to age and sex: the SEARCH study.
*Difference in weight status between type 1 diabetic female and male subjects is significant (P  0.01). Age represents age at time of SEARCH study
visit. Weight categories are defined based on Centers for Disease Control and Prevention definitions of weight status. , underweight/normal; o,
overweight; f, obese.
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Pennsylvania. For ages 0–17 years in the
Chicago, Illinois, registry (29), for youth
with presumed type 1 diabetes, a smaller
difference in incidence rates between Af-
rican American and NHW girls was ob-
served than between African American
and NHW boys. From the Allegheny
County cohort, Libman et al. (27) de-
scribed lower prevalence of diabetes au-
toantibodies among African American
youth with insulin-treated diabetes and
higher prevalence of obesity and other
characteristics commonly associated with
type 2 diabetes among African American
compared with white youth (30). The Al-
legheny County, Philadelphia, or Chicago
registries did not published data by race/
ethnicity or according to diabetes type
and sex within age-group, presumably
due to sample size limitations.
From the SEARCH study, the inci-
dence rates (2002–2003) among African
American youth aged 0–4 and 5–9 years
were significantly lower than NHW youth
(31), and this was true for both boys and
girls. Similar to younger age-groups, inci-
dence was significantly lower among Af-
rican American boys aged 10–14 years
than among NHW boys of the same age.
Taking advantage of the greater sample
size from 4 years of incidence data (2002–
2005), for girls aged 10–14 years, inci-
dence of type 1 diabetes was significantly
higher among the African American girls
(26.1/100,000 per year [95% CI 21.5–
31.8]) than among African American boys
(16.7/100,000 per year [13.1–21.2]) and
was not different from incidence among
NHW girls (29.1/100,000 per year
[26.6–32.0]) (32). Patterns of incidence
were similar for ages 15–19 years com-
pared with patterns for ages 10–14 years.
Thus, the large sample size of the
SEARCH study, inclusive of a total of 450
African American validated cases of pro-
vider-diagnosed type 1 diabetes, allowed
observation of patterns of incidence that
raise at least two critical questions for fu-
ture research. First, what are the genetic,
behavioral, or environmental factors that
protect African American youth aged
10 years and African American boys
aged 10–19 years against the higher inci-
dence of type 1 diabetes observed in their
NHW counterparts? Second, what are the
factors that cause African American girls
aged 10–19 years to lose this protective
advantage? Beginning with the observa-
tion that studies consistently show a
marked race/ethnic difference in obesity
among women and much smaller race/
ethnic differences among men (33), we
propose one avenue for consideration as a
possible explanation for the latter.
Previously, the SEARCH study re-
ported limited evidence for the accelera-
tor hypothesis (34), which postulates that
obesity-mediated insulin resistance con-
tributes to the development of type 1 di-
abetes by accelerating destruction of
pancreatic -cells (35). We observed that
current BMI was associated with younger
age at diagnosis among individuals with
-cell function below the median, as mea-
sured by fasting C-peptide. From the Na-
tional Heart, Lung and Blood Institute
Growth and Health Study (36), adoles-
cent African American girls were more
commonly overweight than NHW girls,
as expected. Interestingly, the rate of new-
onset overweight was similar between Af-
rican American and NHW girls for ages
13–19 years; however, for ages 9 –12
years, new-onset overweight was notably
higher among African American girls
(9.4%) than among NHW girls (5.8%).
Thus, it is possible that earlier (prepuber-
tal) development of obesity in African
American girls is acting during pubertal
development to markedly increase risk at
this vulnerable time for onset of type 1
diabetes.
Banerji (37) has described a high pro-
portion (40%) of African American youth
with type 2 diabetes with DKA at the time
of diagnosis, which may reflect the phe-
nomenon of Flatbush diabetes as ob-
served among African American adults
(38), in which DKA is common despite
absence of common diabetes autoanti-
bodies and low prevalence of HLA geno-
types associated with high risk for type 1
diabetes (39). In the SEARCH study, the
percent of youth with provider-diagnosed
type 2 diabetes who presented with DKA
was 12%, much lower than that re-
ported by Banerji and similar to previ-
ously reported prevalence of DKA at
diagnosis among other race/ethnic groups
in SEARCH (20). Future analyses of
SEARCH data will further explore this is-
sue and will incorporate diabetes autoan-
tibody data as well as HLA genotype.
Glycemic control among African
American youth in the present study was
quite poor, evidenced by 50% of youth
aged 15 years with type 1 diabetes with
A1C 9.5% and 27.5% of youth aged
15 years with type 2 diabetes with sim-
ilarly high A1C. Other studies have doc-
umented worse glycemic control among
African American youth with diabetes
compared with NHW youth (40–42), as
well as more rapid decline in metabolic
control postdiagnosis among African
American youth compared with white
youth with type 1 diabetes (43). Living in
a one-parent household may partly ex-
plain this phenomenon (42,43), and, in
fact, youth from single-parent households
experienced decline in metabolic status
nearly three times as fast as those from
two-parent households (43). Over 50% of
African American SEARCH study partici-
pants with type 1 diabetes reported living
in a single-parent household, as did 63%
of African American youth with type 2
diabetes. In an adult population, medica-
tion adherence did not fully explain ele-
vated A1C observed in African American
compared with white patients (44); thus,
it is possible that biological as well as so-
cial and behavioral factors contribute to
suboptimal glycemic control among Afri-
can American individuals.
Among U.S. adults, the prevalence of
hypertension is higher among African
Americans (33.5%) than among Mexican
Americans (20.7%) or NHWs (28.9%)
(P  0.01) (45), and this pattern is
present among children and adolescents
as well (46). In SEARCH study partici-
pants with type 2 diabetes, nearly a quar-
ter had high blood pressure and a similar
proportion had been told by a provider
that they had high blood pressure. This
observation is of critical public health im-
portance because systolic blood pressure
in childhood has been prospectively asso-
ciated with increased carotid artery
intima-media thickness in adulthood
(47). In addition, among African Ameri-
cans, but not NHWs, elevated blood
pressure in childhood predicted mi-
croalbuminuria in adulthood (48).
The prevalence of elevated LDL
cholesterol was surprisingly high
among African American SEARCH
study youth with either type 1 or type 2
diabetes. Over 90% of youth aged 15
years had LDL cholesterol 70 mg/dl,
and 60% had LDL cholesterol 100
mg/dl. In addition, nearly half of older
youth with type 1 diabetes and 70% of
youth with type 2 diabetes had high
apolipoprotein B (80 mg/dl). These
values are established cut points for
identification of individuals at high risk
for cardiovascular disease based on pre-
dictive models in adult populations
(17) and thus highlight the potential for
substantial future cardiovascular dis-
ease in youth with either type 1 or type
2 diabetes. It is possible that the poor
glycemic control among the African
American youth contributes substan-
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Table 1—Clinical characteristics of African American youth with diabetes, according to current age: the SEARCH study, cases from 2001
(prevalent) and 2002–2005 (incident)
Type 1 diabetes Type 2 diabetes
0–9 years 10–14 years 15 years P*†‡ 10–14 years 15 years P*†‡
n (%)§ 161 (37) 162 (37) 113 (26) 0.0045 81 (38) 131 (62) 0.0006
Diabetes diagnosis
Age at diagnosis (years) (means 
SD) 4.7  2.4 9.1  3.1 12.2  4.4 0.0001 11.7  1 15.1  1.9 0.0001
Symptoms present (% yes) 93.1 88.1 86.4 0.1556 68.4 69.3 0.8876
Diagnosis during routine check-up
(% yes) 9.9 5.7 15.5 0.03 41.3 34.4 0.3178
DKA present at diagnosis (% yes) 30.8 25.9 16.7 0.2401 10.9 13.1 0.7081
Diabetes duration (months) (means 
SD) 19.5  19.4 35.6  36.7 60.9  56.7 0.0001 13.5  8.8 31.6  24.8 0.0001
Diabetes duration categories (%) 0.0001 0.0001
6 months 20.5 11.7 9.7 18.5 9.2
6–12 months 29.2 19.8 10.6 29.6 13.7
12 months 50.3 68.5 79.7 51.9 77.1
Family history of diabetes (% yes)¶ 57.5 71.3 76.1 0.0023 95.0 90.6 0.2493
Current medication
Insulin (% yes) 98.8 96.8 86.5 0.0004 18 27.5 0.1087
Metformin (% yes) 0.6 0 1.8 51.3 38.3
Both insulin and metformin (% yes) 0 3.2 9.9 25.6 22.5
Recent emergency room or
hospitalization**
DKA (% yes) 8.7 10.1 9.7 0.9107 6.2 6.2 0.9955
Hypoglycemia (% yes) 6.8 3.8 5.3 0.4752 1.2 0 0.2059
Current glycemic control
A1C 8.0% 39.7 32.8 29.6 0.0001 74.2 59.6 0.0854
8  A1C  9.5% 39.7 28.2 20.4 12.1 12.8
A1C 9.5% 20.6 38.9 50 13.6 27.5
Current glycemic control (adjusted for
duration)
A1C 8.0% 27.1 26.8 30.8 0.7975 69.3 62.3 0.3972
8  A1C  9.5% 43 28.8 18.2 0.0016 13.6 12 0.7840
A1C 9.5% 24.5 40.2 46 0.0070 16.1 25.3 0.2079
GAD65 positive (% yes) 52.3 64.3 51.6 0.0783 17.2 18.1 0.8809
GAD65 positive (adjusted for
duration) (% yes) 47.4 63.3 55.5 0.0456 16.2 18.4 0.7325
Fasting C-peptide (ng/ml) (adjusted
for duration) (means  SE) 0.4  0.07 0.6  0.06 0.8  0.07 0.0023 3.1  0.2 2.8  0.1 0.3159
Acanthosis (% yes) 11.7 14.6 25.3 0.0163 69.4 79.8 0.1113
Blood pressure
Systolic blood pressure (mmHg)
(means  SD) 92.7  13.2 105  11.5 112.4  11.4 0.0001 116  12.9 118.6  12.6 0.1714
Diastolic blood pressure (mmHg)
(means  SD) 58.3  11.4 65.5  10.8 73.1  10.7 0.0001 71.7  10.5 74.6  10.1 0.0633
High blood pressure (% yes)†† 6.1 7.8 9.8 0.5779 24.7 22.5 0.7378
Ever told by provider they had high
blood pressure (% yes) 2.5 5.1 12.4 0.0026 22.2 23.3 0.8622
Blood pressure (adjusted for duration)
Systolic blood pressure (mmHg)
(means  SE) 93  1.1 105.2  1 112.1  1.2 0.0001 115.5  1.6 118.8  1.2 0.1137
Diastolic blood pressure (mmHg)
(means  SE) 59.3  1.0 65.8  0.9 72.4  1.1 0.0001 72.4  1.3 74.3  1.0 0.2534
High blood pressure (% yes)†† 6.7 8 8.9 0.8465 23.4 22.9 0.9375
Ever told by provider they had high
blood pressure (% yes) 3.1 5.1 9.3 0.1456 22 23.4 0.8255
Continued on facing page
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Table 1—Continued
Type 1 diabetes Type 2 diabetes
0–9 years 10–14 years 15 years P*†‡ 10–14 years 15 years P*†‡
High albumin-to-creatinine ratio
(% yes)‡‡ 6.4 11 11.5 0.3272 15.2 13.4 0.7528
High albumin-to-creatinine ratio
(adjusted for duration) 7.5 11.2 8.9 0.6187 16.9 12.5 0.4867
LDL cholesterol (mg/dl) (means 
SD) 103.3  26.4 97.4  28.7 112.4  35.8 0.0024 103.3  34.3 112.8  31.7 0.0803
LDL cholesterol (mg/dl) (adjusted for
duration) (means  SE) 106.5  3.2 98.2  2.7 110.1  3.3 0.0149 106.7  4.5 111.4  3.3 0.4147
LDL cholesterol
Percent with LDL cholesterol 100
mg/dl§§ 57 39.2 65.5 0.0005 58.6 62.4 0.6402
Percent with LDL cholesterol 100
mg/dl (adjusted for duration) 61.4 40.2 63.1 0.0012 65.2 60.8 0.6029
Percent with LDL cholesterol 70
mg/dl§§ 90.0 87.5 91.7 0.6204 77.6 95.1 0.0008
Percent with LDL cholesterol 70
mg/dl (adjusted for duration) 91.1 88 91.2 0.6687 85.8 95.6 0.0259
Triglycerides (mg/dl) (geometric
means  SD) 50.1  1.5 57.5  1.5 73.9  1.8 0.0001 85.3  1.7 101.5  1.9 0.0732
Triglycerides (mg/dl) (adjusted for
duration) (geometric means 
SE) 52.5  1.1 58.3  1.0 71.4  1.1 0.0003 81.4  1.1 103.4  1.1 0.0227
Triglycerides
Percent with high triglycerides 3 6.7 21.4 0.0001 24.1 40.6 0.0357
Percent with high triglycerides
(adjusted for duration) 3.5 6.8 18.6 0.0058 22.1 41.6 0.0199
HDL cholesterol (mg/dl) (means 
SD) 61  14 57.9  12 54.2  13.2 0.0008 44.7  10.2 45.2  11.4 0.7693
HDL cholesterol (mg/dl) (adjusted for
duration) (means  SE) 61.7  1.3 58.1  1.1 53.7  1.4 0.0002 46.2  1.4 44.6  1.1 0.3615
HDL cholesterol
Percent with low HDL
cholesterol¶¶ 5.8 6.1 13.5 0.0665 36.4 35.9 0.9455
Percent with low HDL cholesterol
(adjusted for duration) 5.7 6.1 13.7 0.0938 27.9 37.2 0.2342
Apolipoprotein B (geometric means 
SD) 67.2  1.3 70.8  1.3 82.7  1.5 0.0003 78.5  1.4 92.2  1.3 0.0077
Apolipoprtein B (adjusted for
duration) (geometric means 
SE) 69.7  1 71.4  1 80.7  1 0.0202 78.9  1.1 91.9  1 0.0210
Apolipoprotein B
Percent with apolipoprotein B 90
mg/dl§§ 11.5 16.1 36.1 0.0008 34.3 51.3 0.0937
Percent with apolipoprotein B 90
mg/dl (adjusted for duration) 13.7 16.4 32.5 0.0273 33.6 51.7 0.1011
Percent with apolipoprotein B 80
mg/dl§§ 21.3 28.7 48.6 0.0020 45.7 69.2 0.0173
Percent with apolipoprotein B 80
mg/dl (adjusted for duration) 25.3 29.5 44.9 0.0642 51.4 67.2 0.1417
Continued on following page
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tially to this finding of high apolipopro-
tein B (49).
Similar to results of national survey
data for adults (50) and youth (51), in the
SEARCH study we previously reported
that African American youth had lower
prevalence of low HDL cholesterol com-
pared with NHW youth (16). Low HDL
cholesterol, however, remains an impor-
tant consideration both for youth with
type 1 and type 2 diabetes. For youth with
type 1 diabetes aged 15 years, 13.5%
had low HDL cholesterol. Of youth with
type 2 diabetes, approximately one-third
had low HDL cholesterol. After adjust-
ment for diabetes duration, the prevalence
of elevated triglyceride concentration in-
creased with age in both type 1 and type 2
diabetes; among youth aged 15 years,
18.6% of youth with type 1 diabetes and
41.6% of those with type 2 diabetes had
elevated triglycerides, again highlighting
the adverse cardiovascular disease risk pro-
file in these youth.
Identification of lifestyle factors that
may contribute to the adverse metabolic
profile described herein for youth with
either type 1 or type 2 diabetes may offer
opportunities for intervention to improve
long-term prognosis. Smoking was re-
ported by 12.4% of youth aged 15 years
with type 1 diabetes and by 13% of youth
with type 2 diabetes. Less than 10% of
youth with either type 1 or type 2 diabetes
consumed 10% of total calories from
saturated fat, and 100% of youth con-
sumed 7% of total calories from satu-
rated fat as recommended for people with
diabetes (52). The vast majority of youth
reported low intake of fruits and vegeta-
bles and dairy products. Although close
to half the youth reported participation in
moderate or vigorous physical activity on
3 days per week, the prevalence of
physical inactivity was high.
Clinical trials of diabetes self-
management interventions among youth
with type 1 diabetes that included behav-
ioral family systems therapy (53) or mo-
tivational interviewing (54) have
demonstrated improvement in glycemic
Table 1—Continued
Type 1 diabetes Type 2 diabetes
0–9 years 10–14 years 15 years P*†‡ 10–14 years 15 years P*†‡
Current lipid-lowering medication
(% yes) 0 0.6 0.9 0.5208 0 3.3 0.1033
Current lipid-lowering medication
(adjusted for duration) 0 0.1 0.01 0.5430 0 3 0.9999
*P value for categorical variables using 2 test for the association between variable levels and age-groups. †P value for continuous variables using ANOVA for the
overall effect of age-group. ‡P value for adjusted variables using logistic regression (categorical variables) or linear regression (continuous variables) for the overall
effect of age-group. §For non–laboratory-based variables, numbers in cells may vary slightly due to occasional missing data. For laboratory-based variables that
required fasting (C-peptide, triglycerides, and LDL cholesterol), 30% of type 1 participants and 25% of type 2 participants had missing values. For the remaining
laboratory-based variables, 20% of participants had missing values. Percents reflect total percent of type 1 diabetes and total percent of type 2 diabetes. Reported
for incident cases only; defined as blood bicarbonate 15 mmol/l or pH 7.25 (venous) or 7.30 (arterial or capillary) or DKA ICD-9 code (250.1) documented
in the medical records or DKA diagnosis mentioned in the medical records with or without biochemical confirmation or ICD-9 code. ¶Family history includes
parents, grandparents, and biological siblings. **Emergency room or hospitalization in the last 6 months. ††High blood pressure defined as measured blood pressure
(systolic and diastolic)  age-, sex-, and height-specific 95th percentile. ‡‡Albumin-to-creatinine ratio 30 	g/mg. §§American Diabetes Association/American
College of Cardiology consensus statement on lipoprotein management (ref. 20). 110 mg/dl. ¶¶40 mg/dl.
Table 2—Behavioral and psychosocial characteristics of African American youth with diabetes, according to current age*: the SEARCH study,
cases from 2001 (prevalent) and 2002–2005 (incident)
Type 1 diabetes Type 2 diabetes
10–14
years 15 years P†‡
10–14
years 15 years P†‡
n (%)§ 162 (59) 113 (41) 0.0031 81 (38) 131 (62) 0.0006
CES-D score (means  SD) 12.9  8.8 11.0  8.3 0.1003 12.9  8.2 15.3  10 0.1085
High CES-D score (% 24) 11.6 10.4 0.7639 9.9 17.4 0.1578
Smoking (% current) 0 12.4 0.0001 4.2 13 0.0481
Diet
Percent total kcal from total fat (means  SD) 39.3  6.0 39.6  5.9 0.7385 39.4  6.3 37.6  6.6 0.0736
Percent total kcal from saturated fat (means  SD) 13.8  2.3 13.9  2.4 0.6902 13.8  2.5 13.3  2.5 0.1756
Percent with 10% of kcal from saturated fat 96.7 96.7 0.9855 96.8 87.9 0.0482
Percent with 7% of kcal from saturated fat 100 100 NA 100 100 NA
Percent servings fruit and vegetables 5 per day 86 84.8 0.8101 84.1 80.8 0.5911
Percent with 2 servings dairy per day 69.4 80.4 0.0689 77.8 83.8 0.3330
Physical activity (% 3–7 days/week moderate or
vigorous activity) 64.8 52.8 0.0575 62 43.5 0.0143
Physical inactivity (% watching television 2 h/day) 68.3 84.0 0.0049 81.7 75.7 0.3345
*These data were collected only among youth aged 10 years. †P value for categorical variables using 2 test for the association between variable levels and
age-groups. ‡P value for continuous variables using ANOVA for the overall effect of age-group. §Percents reflect total percent of type 1 diabetes and total percent
of type 2 diabetes for age categories shown.
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control; however, studies to date gener-
ally have not focused on metabolic status
beyond glycemic control and have not fo-
cused on the African American population.
A large clinical trial now underway among
youth with type 2 diabetes, including a di-
verse study population, will compare three
approaches, one of which includes lifestyle
combined with metformin, with the pri-
mary outcome of time to loss of glycemic
control and an array of secondary outcomes
to include metabolic, clinical, and behav-
ioral outcomes (55).
In conclusion, African American
youth experience a substantial health bur-
den due to both type 1 and type 2 diabe-
tes, and African American youth with
diabetes have generally poor metabolic
status. Lifestyle behaviors likely to be det-
rimental to good health are common. The
high proportion of youth living in single-
parent households and with adverse so-
cioeconomic status may contribute to less
than optimal health behaviors and meta-
bolic status. There are opportunities for
future research to better understand the
occurrence of diabetes in youth particu-
larly related to whether and why over-
weight and obesity may contribute not
only to type 2 diabetes but also to type 1
diabetes, particularly among African
American girls. Research on behavioral
and pharmacologic approaches to sus-
tainable improvements in lifestyle habits,
weight status, and metabolic status in-
cluding glycemia, blood pressure, and
lipid profile among African American
youth with either type 1 or type 2 diabetes
is urgently needed.
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